Related Experiment Videos
Acute pulmonary toxicity in an infant from intravenous amiodarone
C J Daniels1, D A Schutte, S Hammond
1Division/Section of Pediatric Cardiology, The Ohio State University College of Medicine and Columbus Children's Hospital, 43205, USA.
The American Journal of Cardiology
|November 14, 1997
Insights
Intravenous amiodarone effectively treats heart rhythm disorders but can cause acute pulmonary toxicity. This case highlights the diagnostic process for this rare adverse effect in an infant.
Area of Science:
- Cardiology
- Pediatric Medicine
- Pharmacology
Background:
- Intravenous amiodarone is a widely used antiarrhythmic medication.
- Supraventricular and ventricular tachyarrhythmias require effective treatment options.
- Amiodarone carries known risks, including potential pulmonary toxicity.
Abstract:
Intravenous amiodarone is an effective treatment for supraventricular and ventricular tachyarrhythmias. We report a case of acute pulmonary toxicity in an infant from intravenous amiodarone and describe the clinical evaluation and laboratory studies leading to the diagnosis.